Page 6 - Axsm News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Axsm. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Axsm Today - Breaking & Trending Today

Axsome Therapeutics (NASDAQ:AXSM) Releases Earnings Results, Misses Estimates By $0.08 EPS

Axsome Therapeutics (NASDAQ:AXSM – Get Free Report) posted its earnings results on Monday. The company reported ($1.32) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($1.24) by ($0.08), MarketWatch Earnings reports. Axsome Therapeutics had a negative net margin of 101.07% and a negative return on equity of 92.39%. The firm had […] ....

United States , Mark Coleman , William Blair , Franklin Resources Inc , Axsome Therapeutics Company Profile , Axsome Therapeutics Inc , Topco Ltd , Securities Exchange Commission , Royal Bank , Axsome Therapeutics , Get Free Report , Marketwatch Earnings , Director Mark Coleman , Exchange Commission , Financial Advisors , Quantbot Technologies , Axsome Therapeutics Daily , Nasdaq Axsm ,

Axsome Therapeutics, Inc. (NASDAQ:AXSM) Shares Bought by Baldwin Brothers LLC MA

Baldwin Brothers LLC MA lifted its position in Axsome Therapeutics, Inc. (NASDAQ:AXSM – Free Report) by 1.1% in the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 47,995 shares of the company’s stock after acquiring an additional 500 shares during the quarter. […] ....

United States , William Blair , Piper Sandler , Mark Coleman , China Universal Asset Management Co , Tower Research Capital , Axsome Therapeutics Inc , Exchange Commission , Baldwin Brothers , Life Insurance Co , Axsome Therapeutics , Free Report , Financial Advisors , Universal Asset Management , Research Capital , Forest Capital Management , Metropolitan Life Insurance , Life Insurance , Director Mark Coleman , Get Free Report , Visit Holdingschannel , Axsome Therapeutics Daily , Nasdaq Axsm , Sec Filings , Hedge Fund Holdings , Institutional Investor Holdings ,

Axsome Therapeutics, Inc. (NASDAQ:AXSM) Given Average Recommendation of "Moderate Buy" by Brokerages

Axsome Therapeutics, Inc. (NASDAQ:AXSM – Get Free Report) has received a consensus recommendation of “Moderate Buy” from the twelve analysts that are covering the firm, Marketbeat Ratings reports. Two analysts have rated the stock with a hold rating and ten have given a buy rating to the company. The average 1 year target price among […] ....

United States , William Blair , Blackrock Inc , Vanguard Group Inc , Cantor Fitzgerald , Axsome Therapeutics Inc , Axsome Therapeutics Company Profile , Axsome Therapeutics , Get Free Report , Marketbeat Ratings , Get Free , Axsome Therapeutics Daily , Nasdaq Axsm ,

Mizuho Reiterates Buy Rating for Axsome Therapeutics (NASDAQ:AXSM)

Mizuho reaffirmed their buy rating on shares of Axsome Therapeutics (NASDAQ:AXSM – Free Report) in a report released on Monday morning, Benzinga reports. The brokerage currently has a $100.00 price target on the stock. Several other equities research analysts have also commented on AXSM. William Blair reiterated an outperform rating on shares of Axsome Therapeutics […] ....

United States , William Blair , Harbour Investments Inc , Axsome Therapeutics Company Profile , Axsome Therapeutics Inc , Morgan Stanley , Tower Research Capital , China Universal Asset Management Co , Cantor Fitzgerald , Axsome Therapeutics , Free Report , Moderate Buy , Get Free Report , Financial Advisors , Universal Asset Management , Research Capital , Dark Forest Capital Management , Axsome Therapeutics Daily , Nasdaq Axsm , Reiterated Rating ,